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Abstract
Feline immunodeficiency virus (FIV) is a lentivirus that can lead to a syndrome of acquired immune dysfunc-
tion. Infected cats often remain asymptomatic for several years before immune dysfunction leads to an
increased risk for the development of systemic diseases, neoplasia and opportunistic infections. FIV is struc-
turally related to human immunodeficiency virus (HIV) and the pathogenesis of FIV-related disease is similar
to that seen in HIV-infected patients. Observational studies have documented an association between low
plasma vitamin D and HIV infection. Vitamin D status has been shown to be associated with HIV-related dis-
ease progression, morbidity and mortality. The objective of this study was to examine the hypothesis that vita-
min D status, as assessed by serum 25-hydroxyvitamin D [25(OH)D] concentrations, are lower in cats with FIV
infection compared to healthy control cats. Serum 25(OH)D concentrations were measured in 20 healthy cats,
39 hospitalized ill cats and 59 cats infected with FIV. Cats which were FIV infected had significantly lower 25
(OH)D concentrations compared to healthy control cats. Serum 25(OH)D concentrations were not signifi-
cantly different between FIV-infected cats and hospitalized ill cats. Further investigations are warranted to
determine whether vitamin D status influences the prognosis of cats infected with FIV.
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Introduction
Feline immunodeficiency virus (FIV) is a retrovirus
of domestic cats and other Felidae which belongs to
the lentivirus genus (Pedersen et al. 1989). Transmis-
sion primarily occurs by horizontal spread between
adult cats through bites wounds. Risk factors for
infection include cats with outdoor access and cats
with aggressive behaviour (Hartmann 2011). Once
FIV infection has been acquired most cats experi-
ence a transient period of viraemia accompanied by
pyrexia, lymphadenopathy, lethargy, anorexia and
leukopenia (Yamamoto et al. 1988; Pedersen et al.
1989; Hartmann 2011). After several weeks the vir-
aemia subsides and cats often enter a prolonged
asymptomatic phase infection lasting many years.
During this clinically asymptomatic phase there is a
progressive decline in CD4+ T-lymphocytes (Dun-
ham & Jarrett, 2006). Some infected cats will remain
asymptomatic despite this decline in CD4+ T-cells;
however, in other cats the decline in CD4+ T-cells
and resulting immune dysfunction leads to an
increased susceptibility to infections, immune-
mediated diseases and neoplasia (Hartmann 2011).
FIV shares many morphological and pathophysio-
logical features with the human lentivirus, human
immunodeficiency virus (HIV). Like HIV, FIV is
characterized by tropism for lymphocytes, macro-
phages and cells of the central nervous system (Dow
et al. 1990; English et al. 1993). In the host species,
infection with each virus leads to a progressive
acquired immunodeficiency syndrome. The immune
dysfunction seen as a result of HIV and FIV infec-
tions includes cytokine dysregulation, inappropriate
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activation of immune regulatory cells and T-cell
anergy and apoptosis (Tompkins & Tompkins 2008).
Overall, these conditions are associated with a pro-
inflammatory state and an increase in plasma cell
activity with non-specific immunoglobulin produc-
tion.
A large number of studies have investigated the
relationship between serum vitamin D levels, as
assessed by serum 25-hydroxyvitamin D [25(OH)D]
concentrations, and the incidence, progression and
morbidity associated with HIV infection. These stu-
dies have documented a high incidence of low vita-
min D status in patients infected with HIV (Villamor
2006; Lake & Adams 2011). Sub-optimal vitamin D
status and low serum concentrations of the active
form of vitamin D, calcitriol have been associated
with lower CD4+ T-cell counts, HIV progression and
AIDs-related morbidity and survival (Haug et al.
1994; Mehta et al. 2011; Vescini et al. 2011; Kim
et al. 2012). One large-scale study has also identified
vitamin D deficiency as an independent risk factor
for all-cause mortality in HIV-positive patients
(Viard, Jean-Paul, et al. 2011).
The mechanistic link between vitamin D defi-
ciency and HIV progression and AIDS related mor-
bidity and survival may be via the marked
immunomodulatory properties of biologically active
vitamin D, 1,25 dihydroxycholecalciferol (1,25
(OH)2D). The roles of calcitriol within the immune
system include; down-regulation of pro-inflammatory
cytokines, suppression of T-cell activation, shifting of
T-cell responses from a TH1 to TH2 type response,
regulation of monocyte chemotaxis, macrophage
function and dendritic cell phenotypes, and regula-
tion of the production of antimicrobial and antiviral
peptides (Jeremy et al. 2011; Prietl et al. 2013).
Given the known immunomodulatory function of
vitamin D metabolites, it is possible that a combina-
tion of HIV infection and insufficient vitamin D
could be additive in promoting immune dysfunction
in patients infected with HIV. Due to the increasing
evidence of the immunomodulatory effects of vita-
min D and the association between sub-normal vita-
min D levels and increased mortality, there is
growing interest in the benefit of vitamin D supple-
mentation in HIV-positive patients (Villamor 2006).
Given the similarities between HIV and FIV
infection, we hypothesized that the vitamin D sta-
tus of FIV-infected cats would be significantly
lower compared to healthy control cats. The aim
of this retrospective study was to measure serum
25(OH)D concentrations in cats infected with FIV,
healthy cats and a general population of hospital-
ized ill cats. Although it is possible to measure a
number of vitamin D metabolites, vitamin D status
is typically only assessed by measuring 25(OH)D
concentrations (Holick 2009). Although calcitriol is
the active form of vitamin D, assessing calcitriol
concentrations does not provide accurate informa-
tion regarding vitamin D sufficiency or deficiency.
Unlike calcitriol production, the hepatic production
of 25(OH)D is not actively regulated, meaning that
serum 25(OH)D directly reflects either dietary
vitamin D intake or cutaneous synthesis (Holick
2009). The half-life of 25(OH)D is life of approxi-
mately 2–3 weeks reflecting vitamin D intake and
synthesis over this period of time (Holick 2009).
Therefore, 25(OH)D concentrations provide the
most accurate assessment of vitamin D status
(Holick 2009).
Material and methods
Study population
The study was undertaken using residual serum sam-
ples from cats treated at the Hospital for Small Ani-
mals, Royal Dick School for Veterinary Studies,
University of Edinburgh and clinical samples submit-
ted to Langford Veterinary Services, University of
Bristol for determination of FIV status.
Healthy control cats were defined as healthy based
on history, clinical examination findings, routine
haematology and serum biochemistry. Cats enrolled
in this group were blood sampled for the primary
clinical purposes of assessment of PCV, biochem-
istry, FIV status and feline leukaemia virus (FeLV)
status prior to blood donation or for routine FIV/
FeLV testing prior to re-homing. FIV and FeLV sta-
tus was tested using enzyme-linked immunosorbent
assay (ELISA) (SNAP FIV/FeLV Combo Test;
IDEXX Corp., Portland, ME, USA).
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The hospitalized ill cats were consecutively
recruited from cats admitted to Hospital for Small
Animals, Royal Dick School for Veterinary Studies,
University of Edinburgh. Cats were included in this
group if they had a history and clinical examination
findings indicating that diagnostic interventions were
warranted. Signalment, history, recent drug adminis-
tration, haematology results, serum biochemistry
results and final diagnosis were recorded for each
case. FIV status was tested using an in house ELISA
test (SNAP FIV/FeLV Combo Test; or CITE
Combo FIV-FeLV, Agritech Systems, Portland, ME,
USA; or Speed FIV, Virbac Animal Health, La
Seyne sur Mer, France). Cats which tested positive
for FIV were excluded from the hospitalized sick
group. Cats that had been treated with corticos-
teroids in the 2 weeks prior to sample collection
were also excluded. This is because glucocorticoids
have been linked to disturbances in calcium metabo-
lism in humans and companion animals (Hahn et al.
1981; Ramsey et al. 2005).
Samples retrieved for inclusion in the FIV-infected
group were obtained from residual samples submit-
ted to Langford Veterinary Services, University of
Bristol to establish FIV status. Each of the cats
recruited tested positive for FIV by ELISA
(PetCheck FIV antigen ELISA, IDEXX Corp.)
Vitamin D measurement
Following handling of blood samples for routine
diagnostic procedures, serum samples were stored at
20°C until 25(OH)D levels were measured. Sam-
ples were sent frozen in batches and 25(OH)D levels
measured by high-performance liquid chromatogra-
phy (HPLC). Briefly, samples were extracted using
acetonitrile and applied to C18 Silica Sep-paks
(Waters Associates, Milford, MA, USA). Separation
of metabolites was by straight phase HPLC (Waters
Associates) using a Hewlett-Packard Zorbax-Sil Col-
umn (Hichrom, Reading, UK) eluted with hexane:
propan-2-ol:methanol (92:4:4). Serum concentrations
of the two major vitamers of 25(OH)D, 25(OH)D2
(ergocalciferol) and 25(OH)D3 (cholecalciferol),
were measured separately by application to a second
Zorbax-Sil Column eluted with hexane:propan-2-ol
(98:2) and quantified by UV absorbance at 265 nm
and corrected for recovery (sensitivity 5 nmol/L,
intra- and inter-assay coefficients of variation 3.0%
and 4.2%, respectively). Vitamer concentrations
were combined and results expressed as total 25
(OH)D as described previously (Mawer et al. 1990).
The assay laboratory is accredited to ISO 9001:2008
and ISO 13485:2003.
Statistical analyses
Serum 25(OH)D concentrations were compared
between healthy cats, hospitalized ill cats and FIV-
infected cats using the Kruskal–Wallis test with post-
test Dunn’s multiple comparison tests. Statistical anal-
ysis was performed with the commercial software
package GraphPad Prism 6 (Graphpad Software, La
Jolia, CA, USA). P < 0.05 was considered significant.
The study was approved by The Royal Dick School of
Veterinary Studies Ethical Review Committee.
Results
Signalment
The 20 cats in the healthy control group comprised
13 domestic short-haired, 2 domestic long-haired, 2
British short hairs, 2 Maine Coon cats and 1 Bengal
cat. Eleven were neutered males, 6 were neutered
females, two were entire males and one was an entire
female. The ages of the cats in the healthy control
group ranged from 2 to 11 years, with a median age
of 5.5 years.
The 39 cats in the hospitalized ill group comprised
26 domestic short-haired, 5 domestic long-haired, 3
Maine Coon, 2 Bengal, 1 Burmese, 1 Norwegian For-
est Cat and 1 Ragdoll cats. Twenty-four cats were
neutered males, 2 were male entire, and 13 were neu-
tered females. Their ages ranged between 4 months
and 18 years, with a median age of 8 years. The cats
were diagnosed with a range of medical conditions
including: aortic thromboembolism (1), biliary carci-
noma (1) chronic kidney disease (3), congestive heart
failure (2), diabetes mellitus (1), dysautonomia (1),
feline infectious peritonitis (1) fibrosarcoma (1), idio-
pathic chylothorax (1), idiopathic feline lower uri-
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nary tract disease (3), idiopathic megaoesophagus
(1) hepatic disease (1), herpes virus (1), hyperthy-
roidism (7), inflammatory bowel disease (2), gas-
trointestinal lymphoma (2), renal lymphoma (1),
multicentric lymphoma (1), lymphadenopathy (1),
myelodysplasia (1), oral squamous cell carcinoma
(1), pyothorax (3), stomatitis (1) and urolithiasis (1).
There was no clinical data available for the 59 cats
in the FIV-infected group. The samples used were
the stored serum sample from known FIV positive
cats. Clinical data was not available for archived FIV
positive samples.
Serum 25(OH)D concentrations
The median serum 25(OH)D concentration in the
healthy cats was 44.7 ng/mL (range 14.9–61.0 ng/
mL). For the hospitalized ill cats, the median 25
(OH)D concentration was 30.9 ng/mL (range 7.1–
82.40 ng/mL). FIV-infected cats had a median 25
(OH)D concentration of 32.10 ng/mL (range 5.0–
62.4 ng/mL).
Serum 25(OH)D concentrations were significantly
different between healthy control cats, hospitalized
ill cats and FIV-infected cats (P < 0.05); (Fig. 1).
There was a significant difference in 25(OH)D con-
centrations between healthy cats and FIV-infected
cats (P < 0.05) and between healthy cats and hospi-
talized sick cats (P < 0.05). There was no difference
in the serum 25(OH)D concentrations between the
hospitalized ill cats and the FIV-infected cats.
Discussion
The central finding of this study is that FIV-infected
cats have significantly lower serum vitamin D con-
centrations than healthy cats. This observation is
similar to the findings of numerous studies in humans
which have documented lower serum levels of vita-
min D in HIV-positive patients (Lake & Adams
2011). Despite the well-documented association, the
clinical relevancy of the low vitamin D status in
patients with HIV is not fully understood. Since HIV
is a disease of immune dysfunction and calcitriol is
known to have immunomodulatory properties, sev-
eral studies have investigated whether vitamin D
influences the immune response of HIV-positive
patients. As an intracellular virus, HIV replicates
and evades the host-immune response by down regu-
lating cell-mediated immune responses, (Peterlin &
Trono 2003). Physiological doses of calcitriol have
been shown to trigger autophagy and therefore inhi-
bit HIV replication (Campbell & Spector 2011). Fur-
thermore the addition of vitamin D antagonists
decreases the inhibition of HIV-1 replication (Camp-
bell & Spector 2011). In addition calcitriol pre-treat-
ment has also been shown in vitro to decrease HIV
infection by suppressing viral replication, (Connor et
al 1991) to increase monocyte chemotaxis (Girasole
et al. 1990) and to improve the monocyte maturation
defects seen in HIV-positive patient (Haug, Muller
et al. 1996). Calictriol has also been shown to
decrease the number ofMycobacterium avium bacte-
ria in macrophages from HIV-positive patients but
not in HIV-negative controls, suggesting vitamin D
may improve macrophage functions in HIV-positive
patients (Haug et al. 1998). Despite the significant
body of evidence that has shown that vitamin D
metabolites can modulate the immune response in
HIV patients, it is unclear whether vitamin D supple-
mentation can reduce morbidity and mortality in
HIV-positive patients.
The second main finding of this study is that the
vitamin D status of cats with FIV is not lower than
FIV-negative ill cats which have been hospitalized
with a range of conditions. It is unclear if low serum
25(OH)D concentrations are simply a non-specific
change which commonly occurs in ill cats or whether
Fig. 1. Serum 25(OH)D concentrations in healthy cats, hospitalized
ill cats and FIV-infected cats. 25(OH)D, 25-hydroxyvitamin D; FIV,
Feline immunodeficiency virus.
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vitamin D status plays a physiological role in disease
development and progression Potential causes for
low vitamin D in illness in cats include; reduced diet-
ary intake and effects of drugs or haemodilution
from intravenous fluids. Some medications such as
glucocorticoids can infulence vitamin D metabolism
in humans. it is unclear whether many commonly
used drugs can influence vitamin D metabolism in
cats. For example, it has previously been shown that
glucocorticoids do not alter vitamin D metabolism in
dogs (Kovalik et al. 2012a). In light of paucity of
information on how drugs influence vitamin D home-
ostasis, it was elected to take an unbiased approach
of not excluding any cases based on previous medical
therapy , with the exception of corticosteroids as out-
line in the methods and materials. Further research
is needed to conclude if these are relevant factors in
feline medicine. In addition, some studies have sug-
gested that vitamin D may be a negative acute phase
reactant (Waldron et al. 2013).
A growing body of data in human medicine has
shown that 25(OH)D concentrations are negatively
associated with the all-cause mortality and vitamin D
supplementation may ameliorate morbidity (Amrein
et al. 2014; Schottker et al. 2014). The presence of
vitamin D receptors on immune cells combined with
experimental evidence shows that vitamin D can
markedly modulate the immune system may partly
explain why vitamin D status appear to have such an
important association with outcome in a number of
diseases. Less is known about the relationship
between vitamin D status and disease outcomes in
cats although studies have documented low serum 25
(OH)D levels in diseases including inflammatory
bowel disease, gastrointestinal lymphoma and
mycobacterial infection (Lalor et al. 2012, 2014). It
has been demonstrated that low serum concentra-
tions 25(OH)D are associated with an increased risk
of 30 day mortality in sick cats (Titmarsh et al. 2015).
In addition it has been shown that low vitamin D sta-
tus is associated with a poorer response to pred-
nisolone treatment for canine atopic skin disease
(Kovalik et al. 2012b).
There are several limitations in this study. Firstly,
signalment and clinical data were missing from the
FIV-infected cohort. Although this limits our ability
to conclude whether reduced 25(OH)D concentra-
tions are a direct consequence of FIV infection or
due to co-morbid disease, the results do indicate that
cats with FIV infections are not any greater risk of
having lower vitamin D status than FIV negative,
hospitalized ill cats. The other limitation of the study
is that different ELSIA tests were used to assess FIV
status. In general, in house tests for FIV have a simi-
lar specificity and sensitivity, (Hartmann et al. 2007)
making it unlikely that the use of different kits would
adversely affect the validity of our results. Lastly,
both very old and very young cats were enrolled in
the study and age may vary being these groups. Cur-
rently, knowledge regarding the effects of age on
vitamin D status in cats is limited to studies indicat-
ing that 25(OH)D increase over time in growing cats
(Pineda et al. 2013).
Prospective studies investigating the effects of vita-
min D status on susceptibility to illness and treat-
ment outcomes are warranted to investigate the
potential importance between the association of low
vitamin D status and health outcomes. In addition,
future studies which investigate serum vitamin D
concentrations in clinically well and clinically ill FIV-
infected cats would allow the association of sec-
ondary illnesses on vitamin D status to be assessed.
Future studies investigating the effect of dietary com-
position or appetite on vitamin D status would also
be valuable.
Conclusion
In summary, our study has shown that FIV-infected
cats have a significantly lower vitamin D status than
healthy control cats. The vitamin D status of FIV-
infected, hospitalized ill and healthy cats and the
relationship between vitamin D status and long-term
prognosis in FIV-infected cats are deserving of fur-
ther study.
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